Your browser doesn't support javascript.
loading
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19.
Robinson, Philip; Toussi, Sima S; Aggarwal, Sudeepta; Bergman, Arthur; Zhu, Tong; Hackman, Frances; Sathish, Jean G; Updyke, Lawrence; Loudon, Peter; Krishna, Ganesh; Clevenbergh, Philippe; Hernandez-Mora, Miguel Gorgolas; Cisneros Herreros, Jose Miguel; Albertson, Timothy E; Dougan, Michael; Thacker, Amber; Baniecki, Mary Lynn; Soares, Holly; Whitlock, Mark; Nucci, Gianluca; Menon, Sandeep; Anderson, Annaliesa S; Binks, Michael.
Afiliação
  • Robinson P; Infectious Disease, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA.
  • Toussi SS; Pfizer Worldwide Research, Development and Medical, Pfizer Inc, Pearl River, New York, USA.
  • Aggarwal S; Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Bergman A; Pfizer Worldwide Research, Development and Medical, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Zhu T; Pfizer Worldwide Research, Development and Medical, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Hackman F; Pfizer Worldwide Research, Development and Medical, Pfizer Ltd, Cambridge, UK.
  • Sathish JG; Drug Safety Unit, Pfizer Inc, Pearl River, New York, USA.
  • Updyke L; Drug Safety Unit, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Loudon P; Tenpoint Therapeutics, Cambridge, UK.
  • Krishna G; El Camino Health, Mountain View, California, USA.
  • Clevenbergh P; University Hospital Brugmann, Brussels, Belgium.
  • Hernandez-Mora MG; Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
  • Cisneros Herreros JM; Hospital Universitario Virgen Del Rocio, Sevilla, Spain.
  • Albertson TE; UC Davis Medical Center, Sacramento, California, USA.
  • Dougan M; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Thacker A; Regional One Health, Memphis, Tennessee, USA.
  • Baniecki ML; Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Soares H; Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Whitlock M; Early Clinical Development, Pfizer Inc, Cambridge, UK.
  • Nucci G; Pfizer Worldwide Research, Development and Medical, Pfizer Ltd, Cambridge, UK.
  • Menon S; Pfizer Worldwide Research, Development and Medical, Pfizer Ltd, Cambridge, UK.
  • Anderson AS; Pfizer Worldwide Research, Development and Medical, Pfizer Ltd, Cambridge, UK.
  • Binks M; Pfizer Worldwide Research, Development and Medical, Pfizer Ltd, Cambridge, UK.
Open Forum Infect Dis ; 10(8): ofad355, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37559753
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article